Research output per year
Research output per year
Personal profile
Academic discipline
PHARMACOLOGY
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Pierluigi Navarra is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country level (based on research outputs with Scopus ID). Dive into details by clicking on the dots.
-
Drug Repurposing in Pediatric Brain Tumors: Posterior Fossa Ependymoma and Diffuse Midline Glioma under the Looking Glass
Servidei, T., Sgambato, A., Lucchetti, D., Navarra, P. & Ruggiero, A., 2023, In: Frontiers in Bioscience. 28, p. 1-25 25 p.Research output: Contribution to journal › Article › peer-review
-
Emerging Perspectives on the Antiparasitic Mebendazole as a Repurposed Drug for the Treatment of Brain Cancers
Meco, D., Attinà, G., Mastrangelo, S., Navarra, P. & Ruggiero, A., 2023, In: International Journal of Molecular Sciences. 24, p. 1-20 20 p.Research output: Contribution to journal › Article › peer-review
-
mTOR Inhibition Is Effective against Growth, Survival and Migration, but Not against Microglia Activation in Preclinical Glioma Models
Lisi, L., Pizzoferrato, M., Ciotti, G. M. P., Martire, M. & Navarra, P., 2023, In: International Journal of Molecular Sciences. 24, p. 9834-N/AResearch output: Contribution to journal › Article
-
REMIFENTANIL DOES NOT AFFECT HUMAN MICROGLIAL IMMUNE ACTIVATION IN RESPONSE TO PRO-INFLAMMATORY CYTOKINES
Dello Russo, C., Cappoli, N., Tabolacci, E., Sollazzi, L., Navarra, P. & Aceto, P., 2023, In: EXCLI Journal. p. 295-309 15 p.Research output: Contribution to journal › Article
-
Use of High-Dose Nebulized Colistimethate in Patients with Colistin-Only Susceptible Acinetobacter baumannii VAP: Clinical, Pharmacokinetic and Microbiome Features
De Pascale, G., Pintaudi, G., Lisi, L., De Maio, F., Cutuli, S. L., Tanzarella, E. S., Carelli, S., Lombardi, G., Cesarano, M., Gennenzi, V., Ciotti, G. M. P., Grieco, D. L., Posteraro, B., Sanguinetti, M., Navarra, P. & Antonelli, M., 2023, In: Antibiotics. 12, p. 125-N/AResearch output: Contribution to journal › Article